/

Janux Therapeutics

Developing targeted immunotherapies for cancer treatment.

BiotechnologyOncology januxrx.com ↗

Company facts

Founded: 2017
Employees: 109
Headquarters: United States
Type: Public
Listed: NASDAQ: JANX